Feedback

European Commission agrees with Sanofi-GSK to purchase 300 million doses of vaccine for EU needs

Source : 112 Ukraine

Now the EC with partners is discussing the possibility of joint reserving of future vaccines both for their own needs and for low and middle income countries
21:57, 1 August 2020

Open source

The European Commission has reached a preliminary agreement with the Sanofi-GSK pharmaceutical company to purchase a potential COVID-19 vaccine. This was reported by the press service of the European Commission.

The contract with Sanofi-GSK will provide an opportunity for all EU Member States to purchase the vaccine. After the safety and efficacy of the vaccine is confirmed, the European Commission is expected to procure 300 million doses on behalf of all EU member states. The Commission continues to negotiate with other vaccine manufacturers to purchase the medicines.

The European Commission is also committed to guaranteeing access to the vaccine for all Europeans who need it, anywhere in the world, not just at home.

Related: Coronavirus in Ukraine dashboard: online

The Commission is also ready to discuss with international partners pooling resources to jointly reserve future vaccines from companies for both their own needs and for low and middle income countries. High-income countries can act as an inclusive international group of buyers to accelerate vaccine development and maximize access to vaccines for all who need them around the world.

Since May 4, 2020, the EU has raised nearly € 16 billion in the global coronavirus response program.

On June 17, the European Commission unveiled a European strategy to accelerate the development, production and deployment of effective and safe vaccines against COVID-19.

Related: Ministry of Health expands red zone countries list to 120

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more